Developer docs
API playgroundTry for free, no card

Search company profiles

Aseptika

Full company profile

uuid0004ekb

Namestring
Aseptika
Company typeenum
Private
Founded yearint
2007
Descriptiontext

Aseptika is a Cambridge, United Kingdom-based digital health company founded in 2007 that develops inexpensive home monitoring and treatment management devices for patients with Chronic Obstructive Pulmonary Disease (COPD). The company operates its consumer-facing platform under the Activ8rlives brand (activ8rlives.com) and is led by founder, CEO and Managing Director Kevin Auton. Aseptika is structured as a private for-profit entity operating at very small scale (1-10 employees), and its operating model to date has been sustained by non-dilutive grant funding from SBRI Healthcare — a UK NHS-aligned innovation program — across three disclosed rounds in 2013 ($2.94M), 2016 ($1.06M) and 2022 ($0.62M), totaling approximately $4.63M.

Short descriptiontext

Aseptika is a Cambridge, UK-based digital health company founded in 2007 by Kevin Auton that develops low-cost home monitoring and treatment management devices for COPD patients, operating at micro-scale with grant-funded R&D via its Activ8rlives platform.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersCambridge, United Kingdom
HQ citystring
Cambridge
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
COPD home monitoring, respiratory health devices, remote patient monitoring, chronic disease management, home healthcare technology
Industry4 codes
PRIMARYHLAHACAI
Chronic Disease Remote Monitoring (COPD/CHF/HTN, Weight & Symptom Tracking)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLALAFAB
Respiratory & Sleep RPM (COPD, asthma, sleep apnea)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLAHAGAE
Inhalation & Nebulization Devices (Nebulizers, Spacers, Inhaler Accessories)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHLAKANAE
COPD & Chronic Bronchitis Management
NAICS code2 codes
  • Home Health Care Services62161
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Services-Home Health Care Services8082
  • Services-Computer Integrated Systems Design7373
Product category
Respiratory Health Monitoring
No data
Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Aseptika develops an inexpensive home monitoring device and treatment management software for patients with Chronic Obstructive Pulmonary Disease (COPD). The product integrates hardware respiratory sensors with the activ8rlives digital platform to enable daily home-based monitoring of COPD symptoms and support treatment adherence management for patients and healthcare providers in the United Kingdom.

Differentiator
Functional benefit
Problem solved
Product and service2 records
1COPD Home Monitoring Device
CategoryRespiratory Health Monitoring
Description

An inexpensive home monitoring device for patients with Chronic Obstructive Pulmonary Disease (COPD), enabling daily respiratory health monitoring and supporting treatment management outside of clinical settings. Designed for NHS respiratory care programs and UK patients managing chronic respiratory conditions.

2activ8rlives Treatment Management Platform
CategoryDigital Health Software
Description

Digital treatment management platform that supports COPD patients and healthcare providers in tracking respiratory health metrics, medication adherence, and treatment plans. Accessible online via activ8rlives.com.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

AstraZeneca has invested in connected inhaler programs (e.g., partnerships with Adherium) for its respiratory portfolio, making it a large incumbent whose smart inhaler efforts overlap Aseptika's COPD monitoring focus.

TypeBroad incumbent
Description

ResMed acquired Propeller Health and sells broader sleep and respiratory care solutions, making it an incumbent whose connected respiratory platform overlaps Aseptika's home monitoring focus.

TypeDirect peer
Description

Adherium develops smart inhaler sensors and respiratory disease management platforms, directly competing with Aseptika in connected COPD and asthma monitoring devices.

TypeDirect peer
Description

Propeller Health, now owned by ResMed, is a leading digital respiratory health platform offering connected inhaler sensors and COPD/asthma management, the closest direct competitor to Aseptika's offering.

TypeRegional player
Description

Vivisol is a European home respiratory and sleep therapy provider offering home-based oxygen, CPAP, and chronic respiratory management, comparable to Aseptika's UK-focused COPD home monitoring service.

TypeEmerging player
Description

Aptar Pharma develops connected inhaler components and drug delivery devices with embedded sensors, an emerging player addressing the same connected respiratory device category Aseptika targets.

TypeBroad incumbent
Description

Teva markets Digihaler, a connected inhaler platform with integrated sensors, positioning the pharma major as a broad incumbent competing for the same COPD digital therapy category Aseptika targets.

TypeBroad incumbent
Description

GSK is a global respiratory pharma leader with connected inhaler and digital health initiatives that compete for the COPD digital management category Aseptika serves.

TypeEmerging player
Description

Vitalograph manufactures respiratory diagnostic and monitoring devices including COPD screening tools, a UK-based niche player with overlapping home respiratory monitoring capabilities to Aseptika.

TypeBroad incumbent
Description

Philips offers connected respiratory care devices and remote monitoring services for COPD and sleep, positioning it as a broad incumbent in the home respiratory monitoring market.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Aseptika

Respiratory Health Monitoringactiv8rlives.com

Aseptika is a Cambridge, UK-based digital health company founded in 2007 by Kevin Auton that develops low-cost home monitoring and treatment management devices for COPD patients, operating at micro-scale with grant-funded R&D via its Activ8rlives platform.

What Aseptika does

Aseptika is a Cambridge, United Kingdom-based digital health company founded in 2007 that develops inexpensive home monitoring and treatment management devices for patients with Chronic Obstructive Pulmonary Disease (COPD). The company operates its consumer-facing platform under the Activ8rlives brand (activ8rlives.com) and is led by founder, CEO and Managing Director Kevin Auton. Aseptika is structured as a private for-profit entity operating at very small scale (1-10 employees), and its operating model to date has been sustained by non-dilutive grant funding from SBRI Healthcare — a UK NHS-aligned innovation program — across three disclosed rounds in 2013 ($2.94M), 2016 ($1.06M) and 2022 ($0.62M), totaling approximately $4.63M.

Aseptika firmographics

Firmographics
Name
Aseptika
Website
https://activ8rlives.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
1–10 employees
Short description
Aseptika is a Cambridge, UK-based digital health company founded in 2007 by Kevin Auton that develops low-cost home monitoring and treatment management devices for COPD patients, operating at micro-scale with grant-funded R&D via its Activ8rlives platform.
Ownership category
akta.pro rank

Aseptika industry classification

Industry
Product category
Respiratory Health Monitoring
NAICS
Home Health Care Services (62161), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Services-Home Health Care Services (8082), Services-Computer Integrated Systems Design (7373)
akta.pro industry
PRIMARYHLAHACAI
Chronic Disease Remote Monitoring (COPD/CHF/HTN, Weight & Symptom Tracking)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLALAFAB
Respiratory & Sleep RPM (COPD, asthma, sleep apnea)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLAHAGAE
Inhalation & Nebulization Devices (Nebulizers, Spacers, Inhaler Accessories)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHLAKANAE
COPD & Chronic Bronchitis Management

Keywords

  • COPD home monitoring
  • Respiratory health devices
  • Remote patient monitoring
  • Chronic disease management
  • Home healthcare technology

Where Aseptika is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United Kingdom
HQ region
Europe

Markets served

Aseptika business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Aseptika product offering

Product offering

Core offering

Aseptika develops an inexpensive home monitoring device and treatment management software for patients with Chronic Obstructive Pulmonary Disease (COPD). The product integrates hardware respiratory sensors with the activ8rlives digital platform to enable daily home-based monitoring of COPD symptoms and support treatment adherence management for patients and healthcare providers in the United Kingdom.

Differentiator

Problem solved

Functional benefit

Products and services

  • COPD Home Monitoring Device An inexpensive home monitoring device for patients with Chronic Obstructive Pulmonary Disease (COPD), enabling daily respiratory health monitoring and supporting treatment management outside of clinical settings. Designed for NHS respiratory care programs and UK patients managing chronic respiratory conditions.
  • activ8rlives Treatment Management Platform Digital treatment management platform that supports COPD patients and healthcare providers in tracking respiratory health metrics, medication adherence, and treatment plans. Accessible online via activ8rlives.com.

Companies that use Aseptika

Customer profile

Ideal customer profiles1 record

Aseptika technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Aseptika partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves4 records

Expansion highlights3 records

Aseptika competitors and assessment

Company assessment

Broad incumbents

  • AstraZeneca: AstraZeneca has invested in connected inhaler programs (e.g., partnerships with Adherium) for its respiratory portfolio, making it a large incumbent whose smart inhaler efforts overlap Aseptika's COPD monitoring focus.
  • ResMed: ResMed acquired Propeller Health and sells broader sleep and respiratory care solutions, making it an incumbent whose connected respiratory platform overlaps Aseptika's home monitoring focus.
  • Teva Pharmaceutical Industries: Teva markets Digihaler, a connected inhaler platform with integrated sensors, positioning the pharma major as a broad incumbent competing for the same COPD digital therapy category Aseptika targets.
  • GlaxoSmithKline: GSK is a global respiratory pharma leader with connected inhaler and digital health initiatives that compete for the COPD digital management category Aseptika serves.
  • Philips Respiratory Care: Philips offers connected respiratory care devices and remote monitoring services for COPD and sleep, positioning it as a broad incumbent in the home respiratory monitoring market.

Direct peers

  • Adherium: Adherium develops smart inhaler sensors and respiratory disease management platforms, directly competing with Aseptika in connected COPD and asthma monitoring devices.
  • Propeller Health (ResMed): Propeller Health, now owned by ResMed, is a leading digital respiratory health platform offering connected inhaler sensors and COPD/asthma management, the closest direct competitor to Aseptika's offering.

Regional players

  • Vivisol: Vivisol is a European home respiratory and sleep therapy provider offering home-based oxygen, CPAP, and chronic respiratory management, comparable to Aseptika's UK-focused COPD home monitoring service.

Emerging players

  • Aptar Pharma: Aptar Pharma develops connected inhaler components and drug delivery devices with embedded sensors, an emerging player addressing the same connected respiratory device category Aseptika targets.
  • Vitalograph: Vitalograph manufactures respiratory diagnostic and monitoring devices including COPD screening tools, a UK-based niche player with overlapping home respiratory monitoring capabilities to Aseptika.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Aseptika financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Aseptika leadership team

Management profile

Number of profiles

Profiles1 record

Aseptika funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Aseptika M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aseptika

What does Aseptika do?

Aseptika develops an inexpensive home monitoring device and treatment management software for patients with Chronic Obstructive Pulmonary Disease (COPD). The product integrates hardware respiratory sensors with the activ8rlives digital platform to enable daily home-based monitoring of COPD symptoms and support treatment adherence management for patients and healthcare providers in the United Kingdom.

When was Aseptika founded?

Aseptika was founded in 2007. It employs 1 to 10 people.

Where is Aseptika based?

Aseptika is headquartered in Cambridge, United Kingdom, in the Europe region.

Who are Aseptika's main competitors?

Broad incumbents on record are AstraZeneca, ResMed, Teva Pharmaceutical Industries, GlaxoSmithKline and Philips Respiratory Care. Direct peers are Adherium and Propeller Health (ResMed). Vivisol is listed as a regional player. Emerging players are Aptar Pharma and Vitalograph.

Does Aseptika have an API?

No public API is recorded for Aseptika.

What industry is Aseptika in?

Aseptika's product category is Respiratory Health Monitoring. Its primary akta.pro industry code is HLAHACAI, Chronic Disease Remote Monitoring (COPD/CHF/HTN, Weight & Symptom Tracking), with a secondary code of HLALAFAB, Respiratory & Sleep RPM (COPD, asthma, sleep apnea). Its NAICS code is 62161 and its SIC code is 8082.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals